<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Reprod Biol Endocrinol</journal-id><journal-title>Reproductive Biology and Endocrinology : RB&#x00026;E</journal-title><issn pub-type="epub">1477-7827</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19146669</article-id><article-id pub-id-type="pmc">2632643</article-id><article-id pub-id-type="publisher-id">1477-7827-7-4</article-id><article-id pub-id-type="doi">10.1186/1477-7827-7-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Hypothesis</subject></subj-group></article-categories><title-group><article-title>Mouse models for preeclampsia: disruption of redox-regulated signaling</article-title></title-group><contrib-group><contrib id="A1" corresp="yes" contrib-type="author"><name><surname>Banerjee</surname><given-names>Subhasis</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>S.Banerjee@warwick.ac.uk</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Randeva</surname><given-names>Harpal</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>H.Randeva@warwick.ac.uk</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Chambers</surname><given-names>Anne E</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>annechambers2000@yahoo.co.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Clinical Sciences Research Institute, Medical School Building, Gibbet Hill Campus, University of Warwick, Coventry CV4 7AL, UK</aff><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>15</day><month>1</month><year>2009</year></pub-date><volume>7</volume><fpage>4</fpage><lpage>4</lpage><ext-link ext-link-type="uri" xlink:href="http://www.rbej.com/content/7/1/4"/><history><date date-type="received"><day>18</day><month>12</month><year>2008</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2009</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2009 Banerjee et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2009</copyright-year><copyright-holder>Banerjee et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Banerjee               Subhasis                              S.Banerjee@warwick.ac.uk            </dc:author><dc:title>            Mouse models for preeclampsia: disruption of redox-regulated signaling         </dc:title><dc:date>2009</dc:date><dcterms:bibliographicCitation>Reproductive Biology and Endocrinology 7(1): 4-. (2009)</dcterms:bibliographicCitation><dc:identifier type="sici">1477-7827(2009)7:1&#x0003c;4&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1477-7827</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><p>The concept that oxidative stress contributes to the development of human preeclampsia has never been tested in genetically-defined animal models. Homozygous deletion of catechol-O-methyl transferase (Comt-/-) in pregnant mice leads to human preeclampsia-like symptoms (high blood pressure, albuminurea and preterm birth) resulting from extensive vasculo-endothelial pathology, primarily at the utero-fetal interface where maternal cardiac output is dramatically increased during pregnancy. Comt converts estradiol to 2-methoxyestradiol 2 (2ME2) which counters angiogenesis by depleting hypoxia inducible factor-1 alpha (HIF-1 alpha) at late pregnancy. We propose that in wild type (Comt++) pregnant mice, 2ME2 destabilizes HIF-1 alpha by inhibiting mitochondrial superoxide dismutase (MnSOD). Thus, 2ME2 acts as a pro-oxidant, disrupting redox-regulated signaling which blocks angiogenesis in wild type (WT) animals in physiological pregnancy. Further, we suggest that a lack of this inhibition under normoxic conditions in mutant animals (Comt-/-) stabilises HIF-1 alpha by inactivating prolyl hydroxlases (PHD). We predict that a lack of inhibition of MnSOD, leading to persistent accumulation of HIF-1 alpha, would trigger inflammatory infiltration and endothelial damage in mutant animals. Critical tests of this hypothesis would be to recreate preeclampsia symptoms by inducing oxidative stress in WT animals or to ameliorate by treating mutant mice with Mn-SOD-catalase mimetics or activators of PHD.</p></abstract></article-meta></front><body><sec><title>Background</title><p>Approximately 5&#x02013;7% of pregnant women worldwide suffer from common hypertensive pregnancy disorders culminating in preeclampsia (PE), intrauterine growth restriction and premature child birth. PE is the major cause of maternal mortality (80%) in developing nations and in recent years, the perinatal mortality and morbidity in developed countries have increased by five-fold [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. Moreover, the incidence of PE has increased by 40% in the last 15 years [<xref ref-type="bibr" rid="B3">3</xref>]. The most widely accepted cause of pre-eclampsia is reduced utero-placental circulation (superficial implantation of the fetus) due to sub-optimal vascular remodeling of the decidual and the uterine arterioles, secondary to inadequate trophoblast invasion [<xref ref-type="bibr" rid="B4">4</xref>]. Increased oxidative stress and an altered immune response [<xref ref-type="bibr" rid="B5">5</xref>] at the fetal-maternal interface (Th1 bias) are likely effectors contributing to the development of systemic endothelial and renal dysfunctions in the later phase of the disease.</p><p>A series of recent discoveries, specifically the isolation and functional characterization of non-phagocytic NADPH oxidase-homologues in epithelial, endothelial, fibroblast and muscle cells, argue that reactive oxygen species (ROS) are indispensible to both physiological and patho-physiological conditions such as growth, differentiation, apoptosis and senescence [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B8">8</xref>]. The transition from growth to degeneration is finely tuned by the relative concentration of oxidants. For example, in ambient conditions, low levels of H<sub>2</sub>O<sub>2 </sub>(nano-micromolar) are necessary for angiogenesis [<xref ref-type="bibr" rid="B9">9</xref>], while agonist-induced activation resulting in its excessive accumulation (&#x0003e; 150&#x02013;200 &#x003bc;M) prompts endothelial damage [<xref ref-type="bibr" rid="B10">10</xref>]. The scheme shown in Fig. <xref ref-type="fig" rid="F1">1a</xref> depicts the essential role played by ROS in both early and late pregnancy together with the detrimental effect when ROS are produced in excess (oxidative stress).</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Redox-regulated signaling in normal pregnancies and in Comt-deficient mutant mice</bold>. A, Shows that ROS-induced signaling (Lo ROS) is essential for implantation, establishment and maintenance of pregnancy. The absence of ROS (No ROS) or its excessive accumulation (Hi ROS) are detrimental to pregnancy; B, in <italic>Comt</italic><sup>+/+ </sup>mice (WT), 2ME2 production is highest at late pregnancy and blocks vascular growth by destabilizing HIF-1&#x003b1; in physiological pregnancies. The absence of 2ME2 in <italic>Comt</italic><sup>-/- </sup>animals (mutant) would increase oxidative stress and stabilize HIF-1&#x003b1;. The stability of HIF-1&#x003b1; is dependent upon critical concentration of H<sub>2</sub>O<sub>2 </sub>which determines the functional state of prolyl hydroxylases (PHD).</p></caption><graphic xlink:href="1477-7827-7-4-1"/></fig><p>During pregnancy, the maternal energy demand increases significantly to sustain the growing fetus. This demand is met via a substantial increase (30&#x02013;50% compared to the non-gravid state) in the uterine blood flow in the pregnant women [<xref ref-type="bibr" rid="B11">11</xref>]. Consequently the 'shear stress' (dragging frictional force generated by the blood flow), is negotiated by endothelial cell (EC)-derived vasodilatory agonists, nitric oxide (NO<sup>.</sup>) and prostaglandin I<sub>2</sub>. The release of vasodilators from EC is controlled by mitochondrial Ca<sup>+2</sup>-influx (ATP-GPCR and ISP3-ER pathways) as well as NADPH oxidase-dependent mitochondrial O<sub>2</sub><sup>.- </sup>production. The pregnancy-induced adaptation of ROS-regulated Ca<sup>+2 </sup>signaling in the mitochondria of EC is essential for re-establishing physiological laminar flow in uterine vessels [<xref ref-type="bibr" rid="B12">12</xref>]. In extreme circumstances, dysregulation of mitochondrial Ca<sup>+2 </sup>homeostasis due to high ROS, could lead to Ca<sup>+2 </sup>overload of the matrix, triggering apoptosis. The first indication of a mitochondrial involvement in preeclampsia/eclampsia came from a case report where the frequency of the disease was high in a family with inborn mitochondrial defects [<xref ref-type="bibr" rid="B13">13</xref>]. A number of <italic>in vitro </italic>studies on a hypoxia-reoxygenation model of placental culture and plasma oxidant/antioxidant analyses further pointed to mitochondrial involvement by suggesting that ROS could influence trophoblast fusion, migration and apoptosis relevant to preeclampsia [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. In support of this, it is pertinent that homozygous deletion of <italic>SOD-2 </italic>(MnSOD) has the most severe effect on embryonic development in mouse pregnancy compared to that of <italic>SOD-1 </italic>and <italic>SOD-3 </italic>knockouts [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>Reactive oxygen species (ROS) are key mediators of growth factor-dependent redox-regulated signaling in angiogenesis. While &#x0003e; 90% of O<sub>2 </sub>is reduced in mitochondria, NADPH oxidases (Nox2, gp91phox) are the major source of ROS in endothelial cells [<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. The O<sub>2</sub><sup>.- </sup>generated at the outer surface of the plasma membrane is internalized through ion channels, a process which increases the intracellular Ca<sup>+2 </sup>release, activating mitochondrial O<sub>2</sub><sup>.- </sup>production. Thus, NADPH oxidases and mitochondria together perpetuate a cascade of O<sub>2</sub><sup>.- </sup>production in vascular endothelial cells [<xref ref-type="bibr" rid="B19">19</xref>,<xref ref-type="bibr" rid="B20">20</xref>].</p><p>Hypoxia inducible factor -1&#x003b1;(HIF-1&#x003b1;) is a dynamic partner of the heterodimeric transcription factor HIF-1 which is essential for angiogenesis [<xref ref-type="bibr" rid="B21">21</xref>]. Irrespective of the oxygen tension (hypoxic or normoxic), the stability of HIF-1&#x003b1; is determined by it ligation to von Hippel-Lindau tumor suppressor protein, VHL [<xref ref-type="bibr" rid="B22">22</xref>]. Once bound to VHL, HIF-1&#x003b1; undergoes ubiquitination prior to proteosomal degradation. A prerequisite for VHL binding is site-specific hydroxylation of HIF-1&#x003b1; by prolyl hydroxylases (PHD). The transfer of these hydroxyl moieties to HIF-1&#x003b1; by PHD requires O<sub>2 </sub>and 2-oxogluterate as co-substrates, together with reduced iron (Fe<sup>+2</sup>) and ascorbate as cofactors [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. Therefore, prolyl hydroxylases act as negative regulators of HIF-1&#x003b1; since active PHD-Fe<sup>+2 </sup>promote HIF-1&#x003b1; binding to VHL and subsequent degradation. It is apparent that the enzymatic activity of PHD could be modulated by the relative concentration of co-substrates as well as cofactors. Indeed, the stability of HIF-1&#x003b1; in angiotensin II-treated vascular smooth muscle cells under normoxic conditions is due to H<sub>2</sub>O<sub>2</sub>-mediated reduction in cellular ascorbate concentration and increased Fe<sup>+3 </sup>[<xref ref-type="bibr" rid="B25">25</xref>]. It is noteworthy that commonly encountered ROS such as O<sub>2</sub><sup>.- </sup>and OH<sup>. </sup>anions are short-lived and, owing to their limited diffusion capacity, fail to cross the plasma membrane except through ion channels. Therefore, the majority of cellular ROS-effects are mediated via relatively stable H<sub>2</sub>O<sub>2</sub>. This is consistent with genetic, molecular and pharmacological experiments [<xref ref-type="bibr" rid="B26">26</xref>-<xref ref-type="bibr" rid="B29">29</xref>] suggesting that H<sub>2</sub>O<sub>2 </sub>plays a central role in stabilizing HIF-1&#x003b1; by converting PHD-Fe<sup>+2 </sup>to PHD-Fe<sup>+3</sup>.</p><p>Clinical research on preeclampsia (PE) is mostly restricted to observations, <italic>in vitro </italic>correlative studies on placenta and patient serum samples originating from mid-to-late gestation when the disease is fully manifested, long after it initiates at early pregnancy. These problems have underlined the necessity for animal models of PE where the progression of pathogenesis can be traced through longitudinal studies from early pregnancy. Three recently developed mouse models for PE [<xref ref-type="bibr" rid="B30">30</xref>-<xref ref-type="bibr" rid="B32">32</xref>] exhibit hallmarks of the human disease. In one of these models, the critical symptoms of PE (hypertension, proteinurea due to glomerulosclerosis and fetal resorption) were ameliorated by continued treatment with an SOD mimetic, tempol [<xref ref-type="bibr" rid="B31">31</xref>], suggesting that the PE-like symptoms of these model mice are precipitated by disruption of redox-regulated signaling during pregnancy. A further link between redox-regulated signaling and human pregnancy pathology has been provided by the most recently developed animal model for PE [<xref ref-type="bibr" rid="B32">32</xref>]. The homozygous deletion of Catechol-O-methyl transferase (<italic>Comt</italic><sup>-/-</sup>) in pregnant mice results in the loss of 2ME2 which has direct involvement in redox-regulated signaling.</p><p>Despite the advantage of targeted disruption of a specific gene (<italic>Comt</italic>) in the mouse system and similarities in placental cell types in mouse and human, this animal model might be insufficient in understanding all aspects of the development of human preeclampsia and fetal growth restriction. The limitations of the mouse model for preeclampsia stem from intrinsic differences in the physiology of mouse and human pregnancies [<xref ref-type="bibr" rid="B33">33</xref>]. The mode of implantation [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>] differs between mouse and human; there is shallow decidual invasion in mouse compared to extensive uterine remodeling by invasive trophoblasts in human. In addition, the uterine spiral arterioles in mice are remodeled by maternal factors rather than by invasive trophoblasts in human pregnancies [<xref ref-type="bibr" rid="B36">36</xref>], and the endocrine control of mouse pregnancy is mediated by a limited number of placental hormones compared to that of human [<xref ref-type="bibr" rid="B37">37</xref>]. Moreover, the short gestation period (3 weeks) in mice, the incomplete development and birth of altricial young are unlike human pregnancies [<xref ref-type="bibr" rid="B38">38</xref>]. All of these factors limit mouse pregnancy as a model system for human fetal growth restrictions.</p><sec><title>Hypothesis</title><p>2-methoxyestradiol 2 (2ME2) is a natural estradiol metabolite which induces microtubule depolymerisation, inhibits angiogenesis and is a promising anticancer drug by virtue of its ability to target leukaemia cells while sparing normal lymphocytes [<xref ref-type="bibr" rid="B39">39</xref>]. At first glance, the fact that the absence of the 2ME2 metabolite in mutant (<italic>Comt</italic><sup>-/-</sup>) pregnant mice results in placental hypoplasia and vascular pathology to the extent that it leads to a preeclampsia-like phenotype [<xref ref-type="bibr" rid="B32">32</xref>], might appear surprising. However, a paradigm shift with recent discoveries [<xref ref-type="bibr" rid="B6">6</xref>] of redox-regulated signaling pathways for angiogenesis [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>,<xref ref-type="bibr" rid="B40">40</xref>] are consistent with vascular pathology of 2ME2-deficient (<italic>Comt</italic><sup>-/-</sup>) pregnant mice [<xref ref-type="bibr" rid="B32">32</xref>]. It should be emphasized that the temporal requirements for 2ME2 vary in normal pregnancies, its production being extremely low in early pregnancy during the peak period of angiogenesis and high later (third trimester) when placental development is complete [<xref ref-type="bibr" rid="B41">41</xref>,<xref ref-type="bibr" rid="B42">42</xref>].</p><p>Genetic and biochemical studies have established that 2ME2 is a potent inhibitor of MnSOD [<xref ref-type="bibr" rid="B43">43</xref>-<xref ref-type="bibr" rid="B45">45</xref>] and facilitates superoxide (O<sub>2</sub><sup>.-</sup>) production [<xref ref-type="bibr" rid="B44">44</xref>]. In wild-type pregnant mice (<italic>Comt</italic><sup>+/+</sup>), the inhibition of MnSOD at late pregnancy (dpc 12&#x02013;14 in mouse, equivalent to peak activity of 2ME2 at 30&#x02013;35 wks of gestation in human) would disengage NADPH-mitochondrial cross-talk by reducing critical H<sub>2</sub>O<sub>2 </sub>concentration. Lack of sufficient H<sub>2</sub>O<sub>2 </sub>will activate PHD (PHD-Fe<sup>+2</sup>) for hydroxylation of HIF-1&#x003b1; (HIF-1&#x003b1;.OH) and subsequent degradation [see Fig <xref ref-type="fig" rid="F1">1b</xref> and ref [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B29">29</xref>]]. This notion is in agreement with the established anti-angiogenic role of 2ME2 [<xref ref-type="bibr" rid="B46">46</xref>] and inhibition of HIF-1&#x003b1; in WT (<italic>Comt</italic><sup>+/+</sup>) animals [<xref ref-type="bibr" rid="B32">32</xref>]. Such down-regulation of vascular remodeling and placental growth under normoxic conditions at late pregnancy by 2ME2 (peak activity at 30&#x02013;35 wks of gestation), is presumed to be a physiological necessity to circumvent uncontrolled placental invasion which otherwise could potentially lead to pregnancy pathology. Premature induction of 2ME2 during early hypoxic growth (4&#x02013;12 wks of gestation) would be detrimental to pregnancy, since the stability of HIF-1&#x003b1; in early hypoxic development is essential for vascular remodeling. Additionally, 2ME1 (2-methoxyestrone), an analogue of 2ME2 having no inhibitory effect on MnSOD [<xref ref-type="bibr" rid="B45">45</xref>], would fail to correct 2ME2 deficiency in <italic>Comt</italic><sup>-/- </sup>mice.</p><p>In <italic>Comt</italic><sup>-/- </sup>mice, the lack of inhibition of MnSOD under normoxic conditions (late pregnancy) would facilitate untimely accumulation of H<sub>2</sub>O<sub>2 </sub>which is essential for HIF-1&#x003b1; stability [<xref ref-type="bibr" rid="B32">32</xref>]. H<sub>2</sub>O<sub>2 </sub>would block hydroxylation of HIF-1&#x003b1; by inactivating PHD (PHD-Fe<sup>+3</sup>) [<xref ref-type="bibr" rid="B25">25</xref>-<xref ref-type="bibr" rid="B29">29</xref>] This view (Fig <xref ref-type="fig" rid="F1">1b</xref>) is supported by the observation that HIF-1&#x003b1; is labile following injection of 2ME2 in <italic>Comt</italic><sup>-/- </sup>mice at late pregnancy [<xref ref-type="bibr" rid="B32">32</xref>]. Increased accumulation of H<sub>2 </sub>O<sub>2 </sub>(&#x0003e; 200 &#x003bc;M/L) under normoxic conditions together with stable HIF1-&#x003b1; is sufficient to inflict vascular pathology in <italic>Comt</italic><sup>-/- </sup>mice. Moreover, HIF-1&#x003b1; is a potent mediator of myeloid cell (monocytes and macrophages) infiltration at the sites of inflammation [<xref ref-type="bibr" rid="B47">47</xref>] and lipopolysaccharide-induced sepsis [<xref ref-type="bibr" rid="B48">48</xref>]. Therefore stable HIF-1&#x003b1; alone at late pregnancy could elicit preeclampsia-like phenotypes in <italic>Comt</italic><sup>-/- </sup>mice.</p></sec><sec><title>Testing the hypothesis</title><sec><title>Oxidative stress as an inducer of preeclampsia in genetically normal mice</title><p>1. Preeclampsia symptoms in normal pregnant mice could be created by treating the animals with 2ME2. 2ME2 which peaks at third trimester of pregnancy, is a pro-oxidant and rather than an antioxidant as proposed by Kanasaki <italic>et al </italic>[<xref ref-type="bibr" rid="B32">32</xref>]. Therefore, 2ME2 could be detrimental to early hypoxic development. This hypothesis could be tested by daily injection of 2ME2 beginning at 3 days prior to pregnancy up to dpc 17 of gestation in genetically normal mice.</p><p>2. Since 2ME2 at low concentrations (0.3 mM) in combination with rotenone [<xref ref-type="bibr" rid="B44">44</xref>] is a potent inducer of O<sub>2</sub><sup>.-</sup>, the same experiment could be repeated to ensure maximum oxidative effect. The logic behind using the combination is that rotenone at low concentration (50 nM) would direct O<sub>2</sub><sup>.- </sup>production by diverting electron flow from complex 1 of the electron transport chain to O<sub>2</sub>, while non-toxic concentrations of 2ME2 (0.3 &#x003bc;M) would synergistically facilitate O<sub>2</sub><sup>.- </sup>accumulation by inhibiting SOD [<xref ref-type="bibr" rid="B44">44</xref>].</p></sec><sec><title>Elimination of oxidative stress in mutant mice by antioxidants/activator of PHD</title><p>1. The proposed oxidative damage induced by accumulation of H<sub>2</sub>O<sub>2 </sub>in <italic>Comt</italic><sup>-/- </sup>mice could be rescued by treating the animals with synthetic MnSOD/catalase mimetics. Synthetic MnSOD/catalase mimetics have been shown to exhibit both SOD and catalase activities, and some are more potent, stable and cytoprotective than the native antioxidant enzyme SOD [<xref ref-type="bibr" rid="B49">49</xref>].</p><p>2. The preeclampsia phenotype in mutant animals could be rescued by treating the animals with ascorbate or specific activators of PHD (benzopyran or an inhibitor of diacylglycerol kinase, R59949).</p></sec></sec><sec><title>Implications of the hypothesis</title><p>While oxidative stress has been proposed to be central to placental pathogenesis and systemic vasculo-endothelial damage in human preeclampsia and a hypertensive mouse model [<xref ref-type="bibr" rid="B31">31</xref>], the concept has never been tested in genetically-defined animal models. The hypothesis and tests described here might contribute to the understanding of pathophysiologic sequences leading to the clinical manifestation of preeclampsia. Moreover, ROS are indispensible to angiogenesis, trophoblast differentiation, invasion and embryogenesis. The proposed experiments would help evaluate the importance of redox-regulated signaling in early as well as late pregnancy.</p></sec></sec><sec><title>Abbreviations</title><p>(ATP): Adenosine triphosphate; (GPCR): G protein-coupled receptor; (ISP3): Inositol triphosphate; (ER): Endoplasmic reticulum; (<italic>Comt</italic>): Catechol-O-methyl transferase; (2ME2): 2-methoxyestradiol 2; (HIF-1&#x003b1;): Hypoxia induciblefactor-1&#x003b1;; (SOD-1, 2 and 3): Superoxide dismutase 1&#x02013;3; (MnSOD): Mitochondrial superoxide dismutase; (PHD): Prolylhydroxlases; (ROS): Reactive oxygen species; (WT): wild type.</p></sec><sec><title>Competing interests</title><p>The authors declare that they have no competing interests.</p></sec><sec><title>Authors' contributions</title><p>The authors discussed the clinical importance of different mouse models for preeclampsia and developed the hypothesis; SB wrote the manuscript. All authors read and approved the final manuscript.</p></sec></body><back><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacKay</surname><given-names>AP</given-names></name><name><surname>Berg</surname><given-names>CJ</given-names></name><name><surname>Atrash</surname><given-names>HK</given-names></name></person-group><article-title>Pregnancy-related mortality from preeclampsia and eclampsia</article-title><source>Obstet Gynecol</source><year>2001</year><volume>97</volume><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="pmid">11275024</pub-id><pub-id pub-id-type="doi">10.1016/S0029-7844(00)01223-0</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duley</surname><given-names>L</given-names></name></person-group><article-title>Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean</article-title><source>Br J Obstet Gynaecol</source><year>1992</year><volume>99</volume><fpage>547</fpage><lpage>553</lpage><pub-id pub-id-type="pmid">1525093</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>JA</given-names></name><name><surname>Hamilton</surname><given-names>BE</given-names></name><name><surname>Sutton</surname><given-names>PD</given-names></name><name><surname>Ventura</surname><given-names>SJ</given-names></name><name><surname>Menacker</surname><given-names>F</given-names></name><name><surname>Munson</surname><given-names>ML</given-names></name></person-group><article-title>Births: final data for 2003</article-title><source>Natl Vital Stat Rep</source><year>2005</year><volume>54</volume><fpage>1</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">16176060</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redman</surname><given-names>CW</given-names></name><name><surname>Sargent</surname><given-names>IL</given-names></name></person-group><article-title>Latest advances in understanding preeclampsia</article-title><source>Science</source><year>2005</year><volume>308</volume><fpage>1592</fpage><lpage>1594</lpage><pub-id pub-id-type="pmid">15947178</pub-id><pub-id pub-id-type="doi">10.1126/science.1111726</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Chambers</surname><given-names>AE</given-names></name><name><surname>Campbell</surname><given-names>S</given-names></name></person-group><article-title>Is Vitamin E a safe prophylaxis for pre-eclampsia?</article-title><source>Am J Obstet &#x00026; Gynecol</source><year>2006</year><volume>194</volume><fpage>1228</fpage><lpage>1233</lpage><pub-id pub-id-type="pmid">16579948</pub-id><pub-id pub-id-type="doi">10.1016/j.ajog.2005.11.034</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Suh</surname><given-names>YA</given-names></name><name><surname>Arnold</surname><given-names>RS</given-names></name><name><surname>Lassegue</surname><given-names>B</given-names></name><name><surname>Shi</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Sorescu</surname><given-names>D</given-names></name><name><surname>Chung</surname><given-names>AB</given-names></name><name><surname>Griendling</surname><given-names>KK</given-names></name><name><surname>Lambeth</surname><given-names>JD</given-names></name></person-group><article-title>Cell transformation by the superoxide-generating oxidase Mox1</article-title><source>Nature</source><year>1999</year><volume>401</volume><fpage>79</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">10485709</pub-id><pub-id pub-id-type="doi">10.1038/43459</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Geiszt</surname><given-names>M</given-names></name><name><surname>Kopp</surname><given-names>JB</given-names></name><name><surname>Varnai</surname><given-names>P</given-names></name><name><surname>Leto</surname><given-names>TL</given-names></name></person-group><article-title>Identification of Renox, an NAD(P)H oxidase in kidney</article-title><source>Proc Natl Acad Sci USA</source><year>2000</year><volume>97</volume><fpage>8010</fpage><lpage>8014</lpage><pub-id pub-id-type="pmid">10869423</pub-id><pub-id pub-id-type="doi">10.1073/pnas.130135897</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nemoto</surname><given-names>S</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Yu</surname><given-names>ZX</given-names></name><name><surname>Ferrans</surname><given-names>VJ</given-names></name><name><surname>Finkel</surname><given-names>T</given-names></name></person-group><article-title>A role for mitochondrial oxidants as regulators of cellular metabolism</article-title><source>Mol Cell Biol</source><year>2000</year><volume>20</volume><fpage>7311</fpage><lpage>7318</lpage><pub-id pub-id-type="pmid">10982848</pub-id><pub-id pub-id-type="doi">10.1128/MCB.20.19.7311-7318.2000</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Kalyanaraman</surname><given-names>B</given-names></name><name><surname>Nicolosi</surname><given-names>AC</given-names></name><name><surname>Gutterman</surname><given-names>DD</given-names></name></person-group><article-title>Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries</article-title><source>Circ Res</source><year>2003</year><volume>93</volume><fpage>573</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">12919951</pub-id><pub-id pub-id-type="doi">10.1161/01.RES.0000091261.19387.AE</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zafari</surname><given-names>AM</given-names></name><name><surname>Ushio-Fukai</surname><given-names>M</given-names></name><name><surname>Akers</surname><given-names>M</given-names></name><name><surname>Yin</surname><given-names>Q</given-names></name><name><surname>Shah</surname><given-names>A</given-names></name><name><surname>Harrison</surname><given-names>DG</given-names></name><name><surname>Taylor</surname><given-names>WR</given-names></name><name><surname>Griendling</surname><given-names>KK</given-names></name></person-group><article-title>Role of NADH/NADPH oxidase-derived H<sub>2</sub>O<sub>2 </sub>in angiotensin II-induced vascular hypertrophy</article-title><source>Hypertension</source><year>1998</year><volume>32</volume><fpage>488</fpage><lpage>495</lpage><pub-id pub-id-type="pmid">9740615</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thaler</surname><given-names>I</given-names></name><name><surname>Manor</surname><given-names>D</given-names></name><name><surname>Itskovitz</surname><given-names>J</given-names></name><name><surname>Rottem</surname><given-names>S</given-names></name><name><surname>Levit</surname><given-names>N</given-names></name><name><surname>Timor-Tritsch</surname><given-names>I</given-names></name><name><surname>Brandes</surname><given-names>JM</given-names></name></person-group><article-title>Changes in uterine blood flow during human pregnancy</article-title><source>Am J Obstet Gynecol</source><year>1990</year><volume>162</volume><fpage>121</fpage><lpage>125</lpage><pub-id pub-id-type="pmid">2301480</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>FX</given-names></name><name><surname>Bird</surname><given-names>IM</given-names></name></person-group><article-title>Pregnancy-specific modulatory role of mitochondria on adenosine 5'-triphosphate-induced cytosolic [Ca2+] signaling in uterine artery endothelial cells</article-title><source>Endocrinology</source><year>2005</year><volume>146</volume><fpage>4844</fpage><lpage>4850</lpage><pub-id pub-id-type="pmid">16055429</pub-id><pub-id pub-id-type="doi">10.1210/en.2005-0414</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Torbergsen</surname><given-names>T</given-names></name><name><surname>Oian</surname><given-names>P</given-names></name><name><surname>Mathiesen</surname><given-names>E</given-names></name><name><surname>Borud</surname><given-names>O</given-names></name></person-group><article-title>Pre-eclampsia &#x02013; a mitochondrial disease?</article-title><source>Acta Obstet Gynecol Scand</source><year>1999</year><volume>68</volume><fpage>145</fpage><lpage>148</lpage><pub-id pub-id-type="pmid">2589041</pub-id><pub-id pub-id-type="doi">10.3109/00016348909009902</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Walsh</surname><given-names>SW</given-names></name></person-group><article-title>Placental mitochondria as a source of oxidative stress in pre-eclampsia</article-title><source>Placenta</source><year>1998</year><volume>9</volume><fpage>581</fpage><lpage>586</lpage><pub-id pub-id-type="pmid">9859861</pub-id><pub-id pub-id-type="doi">10.1016/S0143-4004(98)90018-2</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tannetta</surname><given-names>DS</given-names></name><name><surname>Sargent</surname><given-names>IL</given-names></name><name><surname>Linton</surname><given-names>EA</given-names></name><name><surname>Redman</surname><given-names>CW</given-names></name></person-group><article-title>Vitamins C and E inhibit apoptosis of cultured human term placenta trophoblast</article-title><source>Placenta</source><year>2008</year><volume>29</volume><fpage>680</fpage><lpage>690</lpage><pub-id pub-id-type="pmid">18653232</pub-id><pub-id pub-id-type="doi">10.1016/j.placenta.2008.04.009</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Melov</surname><given-names>S</given-names></name><name><surname>Coskun</surname><given-names>P</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><name><surname>Tuinstra</surname><given-names>R</given-names></name><name><surname>Cottrell</surname><given-names>B</given-names></name><name><surname>Jun</surname><given-names>AS</given-names></name><name><surname>Zastawny</surname><given-names>TH</given-names></name><name><surname>Dizdaroglu</surname><given-names>M</given-names></name><name><surname>Goodman</surname><given-names>SI</given-names></name><name><surname>Huang</surname><given-names>TT</given-names></name><name><surname>Miziorko</surname><given-names>H</given-names></name><name><surname>Epstein</surname><given-names>CJ</given-names></name><name><surname>Wallace</surname><given-names>DC</given-names></name></person-group><article-title>Mitochondrial disease in superoxide dismutase 2 mutant mice</article-title><source>Proc Natl Acad Sci USA</source><year>1999</year><volume>96</volume><fpage>846</fpage><lpage>851</lpage><pub-id pub-id-type="pmid">9927656</pub-id><pub-id pub-id-type="doi">10.1073/pnas.96.3.846</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ushio-Fukai</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Fukai</surname><given-names>T</given-names></name><name><surname>Dikalov</surname><given-names>SI</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Fujimoto</surname><given-names>M</given-names></name><name><surname>Quinn</surname><given-names>MT</given-names></name><name><surname>Pagano</surname><given-names>PJ</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name><name><surname>Alexander</surname><given-names>RW</given-names></name></person-group><article-title>Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis</article-title><source>Circ Res</source><year>2002</year><volume>91</volume><fpage>1160</fpage><lpage>1167</lpage><pub-id pub-id-type="pmid">12480817</pub-id><pub-id pub-id-type="doi">10.1161/01.RES.0000046227.65158.F8</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dworakowski</surname><given-names>R</given-names></name><name><surname>Alom-Ruiz</surname><given-names>SP</given-names></name><name><surname>Shah</surname><given-names>AM</given-names></name></person-group><article-title>NADPH oxidase-derived reactive oxygen species in the regulation of endothelial phenotype</article-title><source>Pharmacol Rep</source><year>2008</year><volume>60</volume><fpage>21</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">18276982</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muzaffar</surname><given-names>S</given-names></name><name><surname>Shukla</surname><given-names>N</given-names></name><name><surname>Angelini</surname><given-names>GD</given-names></name><name><surname>Jeremy</surname><given-names>JY</given-names></name></person-group><article-title>Superoxide auto-augments superoxide formation and upregulates gp91(phox) expression in porcine pulmonary artery endothelial cells: inhibition by iloprost</article-title><source>Eur J Pharmacol</source><year>2006</year><volume>538</volume><fpage>108</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">16647052</pub-id><pub-id pub-id-type="doi">10.1016/j.ejphar.2006.03.047</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hawkins</surname><given-names>BJ</given-names></name><name><surname>Madesh</surname><given-names>M</given-names></name><name><surname>Kirkpatrick</surname><given-names>CJ</given-names></name><name><surname>Fisher</surname><given-names>AB</given-names></name></person-group><article-title>Superoxide flux in endothelial cells via the chloride channel-3 mediates intracellular signaling</article-title><source>Mol Biol Cell</source><year>2007</year><volume>18</volume><fpage>2002</fpage><lpage>2012</lpage><pub-id pub-id-type="pmid">17360969</pub-id><pub-id pub-id-type="doi">10.1091/mbc.E06-09-0830</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Semenza</surname><given-names>GL</given-names></name><name><surname>Wang</surname><given-names>GL</given-names></name></person-group><article-title>A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation</article-title><source>Mol Cell Biol</source><year>1992</year><volume>12</volume><fpage>5447</fpage><lpage>5454</lpage><pub-id pub-id-type="pmid">1448077</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>Wiesener</surname><given-names>MS</given-names></name><name><surname>Chang</surname><given-names>GW</given-names></name><name><surname>Clifford</surname><given-names>SC</given-names></name><name><surname>Vaux</surname><given-names>EC</given-names></name><name><surname>Cockman</surname><given-names>ME</given-names></name><name><surname>Wykoff</surname><given-names>CC</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Maher</surname><given-names>ER</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><article-title>The tumour suppressor protein VHL targets hypoxia inducible factors for oxygen-dependent proteolysis</article-title><source>Nature</source><year>1999</year><volume>399</volume><fpage>271</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">10353251</pub-id><pub-id pub-id-type="doi">10.1038/20459</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruick</surname><given-names>RK</given-names></name><name><surname>McKnight</surname><given-names>SL</given-names></name></person-group><article-title>A conserved family of prolyl-4-Hydroxylases that modify HIF</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>1337</fpage><lpage>1340</lpage><pub-id pub-id-type="pmid">11598268</pub-id><pub-id pub-id-type="doi">10.1126/science.1066373</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Epstein</surname><given-names>AC</given-names></name><name><surname>Gleadle</surname><given-names>JM</given-names></name><name><surname>McNeill</surname><given-names>LA</given-names></name><name><surname>Hewitson</surname><given-names>KS</given-names></name><name><surname>O'Rourke</surname><given-names>J</given-names></name><name><surname>Mole</surname><given-names>DR</given-names></name><name><surname>Mukherji</surname><given-names>M</given-names></name><name><surname>Metzen</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>MI</given-names></name><name><surname>Dhanda</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>YM</given-names></name><name><surname>Masson</surname><given-names>N</given-names></name><name><surname>Hamilton</surname><given-names>DL</given-names></name><name><surname>Jaakkola</surname><given-names>P</given-names></name><name><surname>Barstead</surname><given-names>R</given-names></name><name><surname>Hodgkin</surname><given-names>J</given-names></name><name><surname>Maxwell</surname><given-names>PH</given-names></name><name><surname>Pugh</surname><given-names>CW</given-names></name><name><surname>Schofield</surname><given-names>CJ</given-names></name><name><surname>Ratcliffe</surname><given-names>PJ</given-names></name></person-group><article-title><italic>C. elegans </italic>EGL-9 and mammalian homologues define a family of dioxygenases that regulate HIF by prolyl hydroxylation</article-title><source>Cell</source><year>2001</year><volume>107</volume><fpage>43</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">11595184</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(01)00507-4</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pag&#x000e9;</surname><given-names>EL</given-names></name><name><surname>Chan</surname><given-names>DA</given-names></name><name><surname>Giaccia</surname><given-names>AJ</given-names></name><name><surname>Levine</surname><given-names>M</given-names></name><name><surname>Richard</surname><given-names>DE</given-names></name></person-group><article-title>Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion</article-title><source>Mol Biol Cell</source><year>2008</year><volume>19</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17942596</pub-id><pub-id pub-id-type="doi">10.1091/mbc.E07-06-0612</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chandel</surname><given-names>NS</given-names></name><name><surname>McClintock</surname><given-names>DS</given-names></name><name><surname>Feliciano</surname><given-names>CE</given-names></name><name><surname>Wood</surname><given-names>TM</given-names></name><name><surname>Melendez</surname><given-names>JA</given-names></name><name><surname>Rodriguez</surname><given-names>AM</given-names></name><name><surname>Schumacker</surname><given-names>PT</given-names></name></person-group><article-title>Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing</article-title><source>J Biol Chem</source><year>2000</year><volume>275</volume><fpage>25130</fpage><lpage>25138</lpage><pub-id pub-id-type="pmid">10833514</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M001914200</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerald</surname><given-names>D</given-names></name><name><surname>Berra</surname><given-names>E</given-names></name><name><surname>Frapart</surname><given-names>YM</given-names></name><name><surname>Chan</surname><given-names>DA</given-names></name><name><surname>Giaccia</surname><given-names>AJ</given-names></name><name><surname>Mansuy</surname><given-names>D</given-names></name><name><surname>Pouyssegur</surname><given-names>J</given-names></name><name><surname>Yaniv</surname><given-names>M</given-names></name><name><surname>Mechta-Grigoriou</surname><given-names>F</given-names></name></person-group><article-title>JunD reduces tumor angiogenesis by protecting cells from oxidative stress</article-title><source>Cell</source><year>2004</year><volume>118</volume><fpage>781</fpage><lpage>794</lpage><pub-id pub-id-type="pmid">15369676</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2004.08.025</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>EL</given-names></name><name><surname>Klimova</surname><given-names>TA</given-names></name><name><surname>Eisenbart</surname><given-names>J</given-names></name><name><surname>Moraes</surname><given-names>CT</given-names></name><name><surname>Murphy</surname><given-names>MP</given-names></name><name><surname>Budinger</surname><given-names>GR</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group><article-title>The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production</article-title><source>J Cell Biol</source><year>2007</year><volume>177</volume><fpage>1029</fpage><lpage>1036</lpage><pub-id pub-id-type="pmid">17562787</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200609074</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>Y</given-names></name><name><surname>Mansfield</surname><given-names>KD</given-names></name><name><surname>Bertozzi</surname><given-names>CC</given-names></name><name><surname>Rudenko</surname><given-names>V</given-names></name><name><surname>Chan</surname><given-names>DA</given-names></name><name><surname>Giaccia</surname><given-names>AJ</given-names></name><name><surname>Simon</surname><given-names>MC</given-names></name></person-group><article-title>Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro</article-title><source>Mol Cell Biol</source><year>2007</year><volume>27</volume><fpage>912</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">17101781</pub-id><pub-id pub-id-type="doi">10.1128/MCB.01223-06</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanayama</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Matsuura</surname><given-names>T</given-names></name><name><surname>Sugimura</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>T</given-names></name><name><surname>Moniwa</surname><given-names>N</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Nakayama</surname><given-names>K</given-names></name></person-group><article-title>Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice</article-title><source>Mol Hum Reprod</source><year>2002</year><volume>8</volume><fpage>1129</fpage><lpage>1135</lpage><pub-id pub-id-type="pmid">12468647</pub-id><pub-id pub-id-type="doi">10.1093/molehr/8.12.1129</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname><given-names>DS</given-names></name><name><surname>Weydert</surname><given-names>CJ</given-names></name><name><surname>Lazartigues</surname><given-names>E</given-names></name><name><surname>Kutschke</surname><given-names>WJ</given-names></name><name><surname>Kienzle</surname><given-names>MF</given-names></name><name><surname>Leach</surname><given-names>JE</given-names></name><name><surname>Sharma</surname><given-names>JA</given-names></name><name><surname>Sharma</surname><given-names>RV</given-names></name><name><surname>Davisson</surname><given-names>RL</given-names></name></person-group><article-title>Chronic tempol prevents hypertension, proteinuria, and poor feto-placental outcomes in BPH/5 mouse model of preeclampsia</article-title><source>Hypertension</source><year>2008</year><volume>51</volume><fpage>1058</fpage><lpage>1065</lpage><pub-id pub-id-type="pmid">18259014</pub-id><pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.107.107219</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kanasaki</surname><given-names>K</given-names></name><name><surname>Palmsten</surname><given-names>K</given-names></name><name><surname>Sugimoto</surname><given-names>H</given-names></name><name><surname>Ahmad</surname><given-names>S</given-names></name><name><surname>Hamano</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Parry</surname><given-names>S</given-names></name><name><surname>Augustin</surname><given-names>HG</given-names></name><name><surname>Gattone</surname><given-names>VH</given-names></name><name><surname>Folkman</surname><given-names>J</given-names></name><name><surname>Strauss</surname><given-names>JF</given-names></name><name><surname>Kalluri</surname><given-names>R</given-names></name></person-group><article-title>Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia</article-title><source>Nature</source><year>2008</year><volume>453</volume><fpage>1117</fpage><lpage>1121</lpage><pub-id pub-id-type="pmid">18469803</pub-id><pub-id pub-id-type="doi">10.1038/nature06951</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carter</surname><given-names>AM</given-names></name></person-group><article-title>Animal models of human placentation-a review</article-title><source>Placenta</source><year>2007</year><volume>28</volume><fpage>S41</fpage><lpage>S47</lpage><pub-id pub-id-type="pmid">17196252</pub-id><pub-id pub-id-type="doi">10.1016/j.placenta.2006.11.002</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adamson</surname><given-names>SL</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Whiteley</surname><given-names>KJ</given-names></name><name><surname>Holmyard</surname><given-names>D</given-names></name><name><surname>Hemberger</surname><given-names>M</given-names></name><name><surname>Pfarrer</surname><given-names>C</given-names></name><name><surname>Cross</surname><given-names>JC</given-names></name></person-group><article-title>Interactions between trophoblast cells and the maternal and fetal circulation in the mouse placenta</article-title><source>Dev Biol</source><year>2002</year><volume>250</volume><fpage>358</fpage><lpage>373</lpage><pub-id pub-id-type="pmid">12376109</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Redline</surname><given-names>RW</given-names></name><name><surname>Lu</surname><given-names>CY</given-names></name></person-group><article-title>Localization of fetal major histocompatibility complex antigens and maternal leukocytes in murine placenta. Implications for maternal-fetal immunological relationship</article-title><source>Lab Invest</source><year>1989</year><volume>61</volume><fpage>27</fpage><lpage>36</lpage><pub-id pub-id-type="pmid">2473277</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pijnenborg</surname><given-names>R</given-names></name><name><surname>Vercruysse</surname><given-names>L</given-names></name><name><surname>Hanssens</surname><given-names>M</given-names></name></person-group><article-title>The uterine spiral arteries in human pregnancy: facts and controversies</article-title><source>Placenta</source><year>2006</year><volume>12</volume><fpage>939</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">16490251</pub-id><pub-id pub-id-type="doi">10.1016/j.placenta.2005.12.006</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malassine</surname><given-names>A</given-names></name><name><surname>Frendo</surname><given-names>JL</given-names></name><name><surname>Evain-Brion</surname><given-names>D</given-names></name></person-group><article-title>A comparison of placental development and endocrine functions between the human and mouse model</article-title><source>Hum Reprod Update</source><year>2003</year><volume>9</volume><fpage>531</fpage><lpage>539</lpage><pub-id pub-id-type="pmid">14714590</pub-id><pub-id pub-id-type="doi">10.1093/humupd/dmg043</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>RD</given-names></name></person-group><article-title>Human reproduction: a comparative background for medical hypotheses</article-title><source>J Reprod Immunol</source><year>2003</year><volume>59</volume><fpage>111</fpage><lpage>135</lpage><pub-id pub-id-type="pmid">12896817</pub-id><pub-id pub-id-type="doi">10.1016/S0165-0378(03)00042-1</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>P</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Oldham</surname><given-names>EA</given-names></name><name><surname>Keating</surname><given-names>MJ</given-names></name><name><surname>Plunkett</surname><given-names>W</given-names></name></person-group><article-title>Superoxide dismutase as a target for the selective killing of cancer cells</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>390</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">11014196</pub-id><pub-id pub-id-type="doi">10.1038/35030140</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Kirk</surname><given-names>JS</given-names></name><name><surname>Venkataraman</surname><given-names>S</given-names></name><name><surname>Domann</surname><given-names>FE</given-names></name><name><surname>Zhang</surname><given-names>HJ</given-names></name><name><surname>Schafer</surname><given-names>FQ</given-names></name><name><surname>Flanagan</surname><given-names>SW</given-names></name><name><surname>Weydert</surname><given-names>CJ</given-names></name><name><surname>Spitz</surname><given-names>DR</given-names></name><name><surname>Buettner</surname><given-names>GR</given-names></name><name><surname>Oberley</surname><given-names>LW</given-names></name></person-group><article-title>Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1alpha and vascular endothelial growth factor</article-title><source>Oncogene</source><year>2005</year><volume>24</volume><fpage>8154</fpage><lpage>8166</lpage><pub-id pub-id-type="pmid">16170370</pub-id></citation></ref><ref id="B41"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>D</given-names></name><name><surname>Sonsalla</surname><given-names>R</given-names></name><name><surname>Kuss</surname><given-names>E</given-names></name></person-group><article-title>Concentrations of 2-methoxyoestrogens in human serum measured by a heterologous immunoassay with an 125I-labelled ligand</article-title><source>Acta Endocrinol (Copenh)</source><year>1983</year><volume>103</volume><fpage>282</fpage><lpage>288</lpage><pub-id pub-id-type="pmid">6858558</pub-id></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sugawara</surname><given-names>J</given-names></name><name><surname>Mitsui-Saito</surname><given-names>M</given-names></name><name><surname>Hoshiai</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>C</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Okamura</surname><given-names>K</given-names></name></person-group><article-title>Circulating endothelial progenitor cells during human pregnancy</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>1845</fpage><lpage>1848</lpage><pub-id pub-id-type="pmid">15585564</pub-id><pub-id pub-id-type="doi">10.1210/jc.2004-0541</pub-id></citation></ref><ref id="B43"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>L</given-names></name><name><surname>Leese</surname><given-names>MR</given-names></name><name><surname>Leblond</surname><given-names>B</given-names></name><name><surname>Woo</surname><given-names>LW</given-names></name><name><surname>Ganeshapillai</surname><given-names>D</given-names></name><name><surname>Purohit</surname><given-names>A</given-names></name><name><surname>Reed</surname><given-names>MJ</given-names></name><name><surname>Potter</surname><given-names>BV</given-names></name><name><surname>Packham</surname><given-names>G</given-names></name></person-group><article-title>Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships</article-title><source>Anticancer Drug Des</source><year>2001</year><volume>16</volume><fpage>209</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">12049479</pub-id></citation></ref><ref id="B44"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pelicano</surname><given-names>H</given-names></name><name><surname>Feng</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Carew</surname><given-names>JS</given-names></name><name><surname>Hileman</surname><given-names>EO</given-names></name><name><surname>Plunkett</surname><given-names>W</given-names></name><name><surname>Keating</surname><given-names>MJ</given-names></name><name><surname>Huang</surname><given-names>P</given-names></name></person-group><article-title>Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>37832</fpage><lpage>37839</lpage><pub-id pub-id-type="pmid">12853461</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M301546200</pub-id></citation></ref><ref id="B45"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Golab</surname><given-names>J</given-names></name><name><surname>Nowis</surname><given-names>D</given-names></name><name><surname>Skrzycki</surname><given-names>M</given-names></name><name><surname>Czeczot</surname><given-names>H</given-names></name><name><surname>Baranczyk-Kuzma</surname><given-names>A</given-names></name><name><surname>Wilczynski</surname><given-names>GM</given-names></name><name><surname>Makowski</surname><given-names>M</given-names></name><name><surname>Mroz</surname><given-names>P</given-names></name><name><surname>Kozar</surname><given-names>K</given-names></name><name><surname>Kaminski</surname><given-names>R</given-names></name><name><surname>Jalili</surname><given-names>A</given-names></name><name><surname>Kopec</surname><given-names>M</given-names></name><name><surname>Grzela</surname><given-names>T</given-names></name><name><surname>Jakobisiak</surname><given-names>M</given-names></name></person-group><article-title>Antitumor effects of photodynamic therapy are potentiated by 2-methoxyestradiol. A superoxide dismutase inhibitor</article-title><source>J Biol Chem</source><year>2003</year><volume>278</volume><fpage>407</fpage><lpage>414</lpage><pub-id pub-id-type="pmid">12409296</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M209125200</pub-id></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moser</surname><given-names>C</given-names></name><name><surname>Lang</surname><given-names>SA</given-names></name><name><surname>Mori</surname><given-names>A</given-names></name><name><surname>Hellerbrand</surname><given-names>C</given-names></name><name><surname>Schlitt</surname><given-names>HJ</given-names></name><name><surname>Geissler</surname><given-names>EK</given-names></name><name><surname>Fogler</surname><given-names>WE</given-names></name><name><surname>Stoeltzing</surname><given-names>O</given-names></name></person-group><article-title>ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo</article-title><source>BMC Cancer</source><year>2008</year><volume>8</volume><fpage>206</fpage><pub-id pub-id-type="pmid">18651980</pub-id><pub-id pub-id-type="doi">10.1186/1471-2407-8-206</pub-id></citation></ref><ref id="B47"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cramer</surname><given-names>T</given-names></name><name><surname>Yamanishi</surname><given-names>Y</given-names></name><name><surname>Clausen</surname><given-names>BE</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>I</given-names></name><name><surname>Pawlinski</surname><given-names>R</given-names></name><name><surname>Mackman</surname><given-names>N</given-names></name><name><surname>Haase</surname><given-names>VH</given-names></name><name><surname>Jaenisch</surname><given-names>R</given-names></name><name><surname>Corr</surname><given-names>M</given-names></name><name><surname>Nizet</surname><given-names>V</given-names></name><name><surname>Firestein</surname><given-names>GS</given-names></name><name><surname>Gerber</surname><given-names>HP</given-names></name><name><surname>Ferrara</surname><given-names>N</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group><article-title>HIF-1alpha is essential for myeloid cell-mediated inflammation</article-title><source>Cell</source><year>2003</year><volume>112</volume><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">12628185</pub-id><pub-id pub-id-type="doi">10.1016/S0092-8674(03)00154-5</pub-id></citation></ref><ref id="B48"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peyssonnaux</surname><given-names>C</given-names></name><name><surname>Cejudo-Martin</surname><given-names>P</given-names></name><name><surname>Doedens</surname><given-names>A</given-names></name><name><surname>Zinkernagel</surname><given-names>AS</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name><name><surname>Nizet</surname><given-names>V</given-names></name></person-group><article-title>Cutting edge: Essential role of hypoxia inducible factor-1alpha in development of lipopolysaccharide-induced sepsis</article-title><source>J Immunol</source><year>2007</year><volume>178</volume><fpage>7516</fpage><lpage>7519</lpage><pub-id pub-id-type="pmid">17548584</pub-id></citation></ref><ref id="B49"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamond</surname><given-names>S</given-names></name><name><surname>Watkinson</surname><given-names>M</given-names></name><name><surname>Rutherford</surname><given-names>T</given-names></name><name><surname>Laing</surname><given-names>K</given-names></name><name><surname>Whiting</surname><given-names>A</given-names></name><name><surname>Smallwood</surname><given-names>A</given-names></name><name><surname>Nargund</surname><given-names>G</given-names></name><name><surname>Campbell</surname><given-names>S</given-names></name><name><surname>Banerjee</surname><given-names>S</given-names></name></person-group><article-title>Gene-specific chromatin damage in human spermatozoa can be blocked by antioxidants that target mitochondria</article-title><source>Reprod Biomed Online</source><year>2003</year><volume>7</volume><fpage>407</fpage><lpage>418</lpage><pub-id pub-id-type="pmid">14656402</pub-id></citation></ref></ref-list></back></article>